Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
The momentum for targeted therapies has downstream implications for clinical laboratories
The company’s patients can use AI to look at trends going back five years
By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement
Consortium hosts large proteomics dataset for neurodegenerative diseases
The skin-based test can be used on children as young as two days old
Smarter operations, automation, and collaboration can strengthen laboratories’ role in early detection
Advances could signal changes for clinical laboratories and at-home testing
The technology has moved from niche to practical for routine diagnostics
The two assays identify threats prior to prostate cancer being diagnosed and after it has undergone extensive treatment, respectively
Platform enhances the interpretability of CBC-based machine-learning models
Current assays often miss diagnoses in the early stages of the disease, delaying treatment